InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · Real-Time Price · USD
10.18
-0.48 (-4.50%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others.

In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers.

The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

InfuSystem Holdings, Inc.
InfuSystem Holdings logo
Country United States
Founded 2005
Industry Medical Devices
Sector Healthcare
Employees 473
CEO Carrie Lachance

Contact Details

Address:
3851 West Hamlin Road
Rochester Hills, Michigan 48309
United States
Phone 248 291 1210
Website infusystem.com

Stock Details

Ticker Symbol INFU
Exchange NYSEAMERICAN
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001337013
CUSIP Number 45685K102
ISIN Number US45685K1025
Employer ID 20-3341405
SIC Code 3841

Key Executives

Name Position
Carrie A. Lachance B.S.N., M.B.A., R.N. President, Chief Executive Officer and Director
Jeanie Latz Corporate Secretary

Latest SEC Filings

Date Type Title
Apr 10, 2026 DEF 14A Other definitive proxy statements
Mar 19, 2026 8-K Current Report
Mar 16, 2026 8-K Current Report
Feb 27, 2026 8-K Current Report
Feb 27, 2026 10-K Annual Report
Feb 24, 2026 8-K Current Report
Feb 17, 2026 SCHEDULE 13G/A Filing
Feb 17, 2026 8-K Current Report
Dec 10, 2025 8-K Current Report
Dec 3, 2025 SCHEDULE 13G Filing